PMC:7443692 / 7790-8157 JSONTXT

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T35","span":{"begin":45,"end":55},"obj":"Species"},{"id":"T36","span":{"begin":332,"end":342},"obj":"Species"}],"attributes":[{"id":"A35","pred":"ncbi_taxonomy_id","subj":"T35","obj":"NCBItxid:2697049"},{"id":"A36","pred":"ncbi_taxonomy_id","subj":"T36","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"of ACE2 as decoy, competitive inhibitors for SARS-CoV-2 infection emphasizes the critical need for understanding the glycosylation profile of ACE2 so that optimally active biologics can be produced (Lei et al., 2020; Monteil et al., 2020).\nTo accomplish the task of characterizing site-specific glycosylation of the trimer Spike of SARS-CoV-2 and the host receptor AC"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T26","span":{"begin":45,"end":55},"obj":"Disease"},{"id":"T27","span":{"begin":56,"end":65},"obj":"Disease"},{"id":"T28","span":{"begin":332,"end":342},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"of ACE2 as decoy, competitive inhibitors for SARS-CoV-2 infection emphasizes the critical need for understanding the glycosylation profile of ACE2 so that optimally active biologics can be produced (Lei et al., 2020; Monteil et al., 2020).\nTo accomplish the task of characterizing site-specific glycosylation of the trimer Spike of SARS-CoV-2 and the host receptor AC"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T908","span":{"begin":3,"end":7},"obj":"Protein"},{"id":"T909","span":{"begin":142,"end":146},"obj":"Protein"}],"attributes":[{"id":"A908","pred":"uniprot_id","subj":"T908","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A909","pred":"uniprot_id","subj":"T909","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"of ACE2 as decoy, competitive inhibitors for SARS-CoV-2 infection emphasizes the critical need for understanding the glycosylation profile of ACE2 so that optimally active biologics can be produced (Lei et al., 2020; Monteil et al., 2020).\nTo accomplish the task of characterizing site-specific glycosylation of the trimer Spike of SARS-CoV-2 and the host receptor AC"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T39","span":{"begin":56,"end":65},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T40","span":{"begin":281,"end":285},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T41","span":{"begin":351,"end":355},"obj":"http://purl.obolibrary.org/obo/IDO_0000531"}],"text":"of ACE2 as decoy, competitive inhibitors for SARS-CoV-2 infection emphasizes the critical need for understanding the glycosylation profile of ACE2 so that optimally active biologics can be produced (Lei et al., 2020; Monteil et al., 2020).\nTo accomplish the task of characterizing site-specific glycosylation of the trimer Spike of SARS-CoV-2 and the host receptor AC"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T29","span":{"begin":117,"end":130},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T30","span":{"begin":295,"end":308},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"of ACE2 as decoy, competitive inhibitors for SARS-CoV-2 infection emphasizes the critical need for understanding the glycosylation profile of ACE2 so that optimally active biologics can be produced (Lei et al., 2020; Monteil et al., 2020).\nTo accomplish the task of characterizing site-specific glycosylation of the trimer Spike of SARS-CoV-2 and the host receptor AC"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T27","span":{"begin":117,"end":130},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T28","span":{"begin":295,"end":308},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"of ACE2 as decoy, competitive inhibitors for SARS-CoV-2 infection emphasizes the critical need for understanding the glycosylation profile of ACE2 so that optimally active biologics can be produced (Lei et al., 2020; Monteil et al., 2020).\nTo accomplish the task of characterizing site-specific glycosylation of the trimer Spike of SARS-CoV-2 and the host receptor AC"}

{"project":"2_test","denotations":[{"id":"32841605-32332765-19659500","span":{"begin":211,"end":215},"obj":"32332765"},{"id":"32841605-32333836-19659501","span":{"begin":233,"end":237},"obj":"32333836"}],"text":"of ACE2 as decoy, competitive inhibitors for SARS-CoV-2 infection emphasizes the critical need for understanding the glycosylation profile of ACE2 so that optimally active biologics can be produced (Lei et al., 2020; Monteil et al., 2020).\nTo accomplish the task of characterizing site-specific glycosylation of the trimer Spike of SARS-CoV-2 and the host receptor AC"}